SCHEMBL6813895

SCHEMBL6813895

CCOC(=O)COc1ccc(CCO)cc1C#N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.49
CYP4A11 Q02928 1/20 0.49
CYP2D6 P10635 3/20 0.45
ADRB2 P07550 2/20 0.45
SLC6A2 P23975 2/20 0.45
SLC6A4 P31645 2/20 0.45
CASR P41180 2/20 0.45
SLC6A3 Q01959 2/20 0.45
KCNH2 Q12809 2/20 0.45
SQOR Q9Y6N5 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 2/20 0.43
NLRP3 Q96P20 1/20 0.43
S1PR1 P21453 2/20 0.42
ABCB1 P08183 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6813655 0.89 CYP2D6 (0.44) CYP2D6ADRB2SLC6A2SLC6A4CASR
SCHEMBL6818076 0.85 CYP2D6 (0.42) CYP2D6ADRB2SLC6A2SLC6A4CASR
SCHEMBL14026553 0.83 NPC1 (0.50) SQORNPC1RAB9ATP53HSD17B10
SCHEMBL6809923 0.82 CYP4F2 (0.54) CYP4F2CYP4A11ALDH1A1
SCHEMBL2495570 0.81 ALDH1A1 (0.52) NPC1RAB9ATP53HSD17B10ALDH1A1
SCHEMBL15074081 0.81 POLB (0.48) SQORNPC1RAB9ATP53HSD17B10
SCHEMBL6809807 0.81 ALDH1A1 (0.61) CYP4F2CYP4A11NPC1RAB9AALDH1A1
SCHEMBL13946935 0.79 ALDH1A1 (0.44) SQORNPC1RAB9ATP53HSD17B10
SCHEMBL14026556 0.78 PTGDR2 (0.49) NPC1RAB9ATP53HSD17B10ALDH1A1
SCHEMBL6818066 0.78 CYP4F2 (0.49) CYP4F2CYP4A11ALDH1A1S1PR1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095932-B1 PHENOXYACETIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME KISSEI PHARMACEUTICAL (JP) 2004-05-19 EP disclosed
US-6538152-B1 Obesity, hyperglycemia, urinary incontinence, intestinal or biliary calculi hypermotility, pollakiuria and depression treatment KISSEI PHARMACEUTICAL CO., LTD. (JP) 2003-03-25 US disclosed
EP-1095932-A1 PHENOXYACETIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Kissei Pharmaceutical Co., Ltd. (JP) 2001-05-02 EP disclosed